“…In total, 20 genes with mononucleotide (mono-), dinucleotide (di-), trinucleotide (tri-), tetranucleotide (tetra-), pentanucleotide (penta-) or compound (more than one type of repeat motif) MSs were selected for screening. Cancer-associated genes, including ARID1A, APC, BAX, BRAF, CDKN1A, CDX2, CTNNB1, ERBB2, E2F4, MCC, PTN, PTEN, PRR11, RUNX3, TGFBRII and TP53, which have been reported to be associated with GC in the literature, and MMR genes, including MSH2, MLH1, MGMT and PMS2, were included in the present study (24)(25)(26)(27)(28)(29)(30)(31). In total, 91 MS loci were selected from the 5' untranslated region (UTR), intron, exon or 3'UTR of these 20 genes using the SSRHunter software (v1.3) (Li Qiang, Nanjing Agricultural University) and manual searching (Table SI), then primers for each selected MS were designed based on the flanking sequence using Primer Blast in the Pubmed website (https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.…”